CHRONIC GRANULOMATOUS DISEASE (CGD)
Clinical trials for CHRONIC GRANULOMATOUS DISEASE (CGD) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE (CGD) trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE (CGD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene fix for rare immune disease shows promise in early trial
Disease control ENROLLING_BY_INVITATIONThis study tests a gene therapy for people with X-linked chronic granulomatous disease (X-CGD), a rare immune disorder that leads to severe infections. The treatment takes a patient's own stem cells, adds a working copy of the faulty gene, and returns them to the body after mild …
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Double transplant offers hope for kids with rare immune diseases
Disease control ENROLLING_BY_INVITATIONThis study tests a new approach for people aged 5 to 45 with primary immune disorders and severe lung damage. Participants receive a double lung transplant followed by a stem cell transplant from the same donor. The goal is to see if this combination is safe and can help the body…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE (CGD)
Phase: PHASE1, PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 07, 2026 18:41 UTC